SCI文章投稿经验技巧(MedSci)

2010-01-01 MedSci原创 MedSci原创

SCI论文的关键点 SCI文章对于我们每个人来说,都非常重要。那么一篇文章能不能发表SCI杂志,有哪些关键点?MedSci总结有几个关键性环节: 1、首先当然是文章的设计,MedSci编辑经常发现作者递送过来的文章一个重要的问题就是设计存在缺陷,不是分组缺少,就是样本量过低,或缺少对照,或各部分实验逻辑性不强,这些致命性缺陷是困扰许多作者的关键问题。 2

SCI论文的关键点

SCI文章对于我们每个人来说,都非常重要。那么一篇文章能不能发表SCI杂志,有哪些关键点?MedSci总结有几个关键性环节:

1、首先当然是文章的设计,MedSci编辑经常发现作者递送过来的文章一个重要的问题就是设计存在缺陷,不是分组缺少,就是样本量过低,或缺少对照,或各部分实验逻辑性不强,这些致命性缺陷是困扰许多作者的关键问题。

2、写作。这里指中文的写作,而不是英文语言。许多中文杂志对文章的篇幅要求非常严格,文章非常短小。因此,许多作者写习惯了中文文章,这些写作方式来写作英文文章,实在差强人意。尤其是科研类文章,更是难以入眼。虽然研究工作做了不少,但写得不理想。建议经常读读SCI文章,给人感觉很丰富,充实。

3 英文语言。语言是打动编辑的关键之一,我们知道谁也不愿意看难以读懂的文章。我们要看那些写作很差的文章时,第一感觉是头痛!这样的文章,编辑何谈给出好的评价?!相反,语言写得出色的话,只要质量尚可,编辑基本都会给返修的意见。

4 投稿。这里面又分为选择杂志,投递,与编辑交流等多个环节。而下面仔细讲解这一部分。

投稿的一般过程

(1)选择合适的SCI期刊。据统计,大部分作者关注的期刊不超过20个,而略有接触的期刊也少于50个。而相对几千种SCI期刊来说,确实不够。选择期刊,建议利用MedSci的智能影响因子查询系统和投稿建议系统 https://www.medsci.cn/sci/,可以结合专业、最近的影响因子表,和他人经验来综合选择要投递的期刊,并进入该期刊查询系统查询近年来的文章走向。我们这个系统中提供了几乎全部杂志的主页链接和杂志的简单介绍,方便快速掌握各个不同杂志的特点。

(2)下载Introduction for submission。只要到每个杂志的首页,打开submit paper一栏,点击Introduction查看或下载即可。

(3)稿件及其相关材料准备-Preparation:Manuscript.doc、Tables.doc、Figures.tiff(jpg等)、Cover letter,有时还有Title page、Copyright agreement、Conflicts of interest等。

(4)网上投稿-Submit a manuscript:先到每个杂志的首页,打开submit paper一栏,先以通讯作者的身份register一个账号,然后以author login身份登录,按照提示依次完成:Select Article Type、Enter Title、Add/Edit/Remove Authors、Submit Abstract、Enter Keywords、Select Classifications、Enter Comments、Request Editor、Attach Files,最后下载pdf,查看无误后,即可到投稿主页approve submission或直接submit it。 当然,不少杂志采用email投稿,这时候,你需要注册一个hotmail或yahoo,或gmail信箱,然后将cover letter的内容略修改作为信的内容,将文章各部分作为附件发送过去。一般不建议用国内的信箱,因为不少国外的杂志对国内的信箱是屏蔽的。

(5)定期关注稿件状态-Status:Submit New Manuscript、Submissions Sent Back to Author、Icomplete Submissions、Sbmissions Waiting for Author's Approval、Submissions Being Processed、Submissions Needing Revision、Rvisions Sent Back to Author、Icomplete Submissions Being Revised、Risions Waiting for Author's Approval、Revisions Being Processed、Declined Revisions。一般来说,投稿后,一周以内便可以进入审稿状态,1-3个月会有初审结果。如何关注呢,如果是你自行投稿,建议三天,一周,半个月,一个月,两个月均check一次。如果接受MedSci服务,我们的工作人员会根据计划不断检查你的文章状态,第一时间反馈给您消息。

(6)修回稿的投递-Submitted the revised manuscript:主要修改revised manuscript、response to the reviewers、cover letter,关键是response letter,这非常关键,要逐条回复reviewers的意见,这里面技巧相当多。程序是进入投稿主页main menu,点击revise,仍然按照原先程序投递(近似于4),切记把修改的标题、摘要和回复信等内容要修改。最后上传附件时,先把留下来且未修改的材料前打钩(表示留下不变),然后点击next,再上传已经修改的材料(主要包括revised manuscript、response to the reviewers、cover letter等),最后下载pdf,查看无误后,即可到投稿主页approve submission或直接submit it。

(7)校样-Correct the proof:一般编辑部先寄出三个电子文档,包括Query、Proofs、p-annotate,有时也可能伴有纸质文档校样。校样后通过E-mail寄出即可,或通过email确认。一般校样作者自行核对,我们MedSci有专门的校样工作人员,可以检查出在校样过程中,发现的一些细微错误。对文章进行最后的完善。

(8)版权协议-Copyright agreement和利益冲突-Conflicts of interest:一般首次投稿时就需要提供,但也有少数杂志是Accepted之后才需要提供。

(9)付款。一般文章确认接收后,有付款的过程。不少作者也不熟悉,对方会通过email送过来一个付款的单子。可以根据上面要求进行付款,付款可以由学校或医院转款,或采用信用卡付款均可。

投稿经验小技巧

1、正确选择对口的SCI期刊。建议选择我们的“发表支持(publication support)服务”,我们会全程为大家提供专业的服务。当然如果您比较熟练,也可以自行选择期刊。原则上是先投递高影响因子的杂志,然后不断降低IF。建议参考文献用软件管理,如endnote或reference manage,这样改投另外一种杂志,文献管理起来会比较方便。当然,少数情况,低分杂志投不中,有可能是杂志选择不合适,有时甚至可以向略高一些分数的杂志进行投稿,也有投中的。

2、不能进行一稿两投。这是严禁的!

3、如何正确选择必需推荐的审稿人?一般来说,除杂志有要求,或你研究的领域非常狭窄外,大部分不推荐编辑。如果推荐的审稿人,但你还是尽量选择同行中的小专家。但这也与你的投稿目的有关,若十分自信文章的创新性和中肯意见,你可以从参考文献中挑选大专家。

4、如何催稿?一般来说,根据这个杂志通常审稿周期来定。具体审稿周期,可以参考投稿系统https://www.medsci.cn/sci/ 如果时间仍然在审稿周期内,不建议询问。例如,一个杂志审稿周期在2个月,因此,1个月的时个,切记询问!如果超过2个月的话,可以询问,但写信一定要委婉!!否则你的催稿信就成了拒稿信了。

5、如何提高一次投稿的成功率?文章本身的创新性是第一位因素,对口期刊选择、文章格式完美、语句通顺(尤其符合英文习惯)等也很重要。

6、版权协议和利益冲突表格要谨慎填写。签名时尽量不要代签,以免被编辑发现时的尴尬。

7、尽可能参照投稿说明,认真修改手稿格式。这一点是衡量一位科研工作者的严谨程度,建议大家认真阅读Introduction for submission,逐条地改正,以防延误同行评审时间。

8、修回后投稿一定要核对初稿中改正的地方:标题、摘要、cover letter等。

9、要了解此刊是否需要审稿费和版面费?大家都知道版面费一般都是美元或欧元的,有些杂志收费很贵。少数杂志审稿也收费,大部分杂志是彩图收费制,彩图一张在300-600美元/欧元之间,仍然是比较贵的。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=37457, encodeId=72e43e45776, content=Perecft answer! That really gets to the heart of it!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=duygu, createdTime=Sun Sep 27 09:12:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35639, encodeId=01dc3563943, content=如何寻求你们的帮助呢?比如,论文润色,以及发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e16e1638589, createdName=chynmgchy, createdTime=Sat Aug 15 18:17:00 CST 2015, time=2015-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35433, encodeId=053e3543326, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Tue Aug 11 19:11:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7162, encodeId=969fe162ff, content=很有指导意义。好文!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf0a94763, createdName=guhs, createdTime=Tue Jan 28 22:14:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4631, encodeId=182c46318b, content=好东西~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973966269, createdName=zhanclean, createdTime=Tue Aug 21 15:47:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240, encodeId=b77c1240a5, content=Please add line numbering to your text file. <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gwl333333, createdTime=Tue May 11 16:19:00 CST 2010, time=2010-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195, encodeId=16a91195f1, content=请问这个Journal of Pharmaceutical and Biomedical Analysis需要版面费和审稿费吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c116797, createdName=niuniuyun, createdTime=Wed Apr 14 17:32:00 CST 2010, time=2010-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605517, encodeId=77bb160551ea9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jan 03 07:33:00 CST 2010, time=2010-01-03, status=1, ipAttribution=)]
    2015-09-27 duygu

    Perecft answer! That really gets to the heart of it!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=37457, encodeId=72e43e45776, content=Perecft answer! That really gets to the heart of it!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=duygu, createdTime=Sun Sep 27 09:12:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35639, encodeId=01dc3563943, content=如何寻求你们的帮助呢?比如,论文润色,以及发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e16e1638589, createdName=chynmgchy, createdTime=Sat Aug 15 18:17:00 CST 2015, time=2015-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35433, encodeId=053e3543326, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Tue Aug 11 19:11:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7162, encodeId=969fe162ff, content=很有指导意义。好文!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf0a94763, createdName=guhs, createdTime=Tue Jan 28 22:14:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4631, encodeId=182c46318b, content=好东西~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973966269, createdName=zhanclean, createdTime=Tue Aug 21 15:47:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240, encodeId=b77c1240a5, content=Please add line numbering to your text file. <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gwl333333, createdTime=Tue May 11 16:19:00 CST 2010, time=2010-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195, encodeId=16a91195f1, content=请问这个Journal of Pharmaceutical and Biomedical Analysis需要版面费和审稿费吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c116797, createdName=niuniuyun, createdTime=Wed Apr 14 17:32:00 CST 2010, time=2010-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605517, encodeId=77bb160551ea9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jan 03 07:33:00 CST 2010, time=2010-01-03, status=1, ipAttribution=)]
    2015-08-15 chynmgchy

    如何寻求你们的帮助呢?比如,论文润色,以及发表

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=37457, encodeId=72e43e45776, content=Perecft answer! That really gets to the heart of it!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=duygu, createdTime=Sun Sep 27 09:12:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35639, encodeId=01dc3563943, content=如何寻求你们的帮助呢?比如,论文润色,以及发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e16e1638589, createdName=chynmgchy, createdTime=Sat Aug 15 18:17:00 CST 2015, time=2015-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35433, encodeId=053e3543326, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Tue Aug 11 19:11:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7162, encodeId=969fe162ff, content=很有指导意义。好文!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf0a94763, createdName=guhs, createdTime=Tue Jan 28 22:14:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4631, encodeId=182c46318b, content=好东西~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973966269, createdName=zhanclean, createdTime=Tue Aug 21 15:47:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240, encodeId=b77c1240a5, content=Please add line numbering to your text file. <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gwl333333, createdTime=Tue May 11 16:19:00 CST 2010, time=2010-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195, encodeId=16a91195f1, content=请问这个Journal of Pharmaceutical and Biomedical Analysis需要版面费和审稿费吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c116797, createdName=niuniuyun, createdTime=Wed Apr 14 17:32:00 CST 2010, time=2010-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605517, encodeId=77bb160551ea9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jan 03 07:33:00 CST 2010, time=2010-01-03, status=1, ipAttribution=)]
    2015-08-11 pine007

    好文章

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=37457, encodeId=72e43e45776, content=Perecft answer! That really gets to the heart of it!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=duygu, createdTime=Sun Sep 27 09:12:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35639, encodeId=01dc3563943, content=如何寻求你们的帮助呢?比如,论文润色,以及发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e16e1638589, createdName=chynmgchy, createdTime=Sat Aug 15 18:17:00 CST 2015, time=2015-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35433, encodeId=053e3543326, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Tue Aug 11 19:11:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7162, encodeId=969fe162ff, content=很有指导意义。好文!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf0a94763, createdName=guhs, createdTime=Tue Jan 28 22:14:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4631, encodeId=182c46318b, content=好东西~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973966269, createdName=zhanclean, createdTime=Tue Aug 21 15:47:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240, encodeId=b77c1240a5, content=Please add line numbering to your text file. <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gwl333333, createdTime=Tue May 11 16:19:00 CST 2010, time=2010-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195, encodeId=16a91195f1, content=请问这个Journal of Pharmaceutical and Biomedical Analysis需要版面费和审稿费吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c116797, createdName=niuniuyun, createdTime=Wed Apr 14 17:32:00 CST 2010, time=2010-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605517, encodeId=77bb160551ea9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jan 03 07:33:00 CST 2010, time=2010-01-03, status=1, ipAttribution=)]
    2014-01-28 guhs

    很有指导意义。好文!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=37457, encodeId=72e43e45776, content=Perecft answer! That really gets to the heart of it!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=duygu, createdTime=Sun Sep 27 09:12:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35639, encodeId=01dc3563943, content=如何寻求你们的帮助呢?比如,论文润色,以及发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e16e1638589, createdName=chynmgchy, createdTime=Sat Aug 15 18:17:00 CST 2015, time=2015-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35433, encodeId=053e3543326, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Tue Aug 11 19:11:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7162, encodeId=969fe162ff, content=很有指导意义。好文!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf0a94763, createdName=guhs, createdTime=Tue Jan 28 22:14:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4631, encodeId=182c46318b, content=好东西~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973966269, createdName=zhanclean, createdTime=Tue Aug 21 15:47:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240, encodeId=b77c1240a5, content=Please add line numbering to your text file. <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gwl333333, createdTime=Tue May 11 16:19:00 CST 2010, time=2010-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195, encodeId=16a91195f1, content=请问这个Journal of Pharmaceutical and Biomedical Analysis需要版面费和审稿费吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c116797, createdName=niuniuyun, createdTime=Wed Apr 14 17:32:00 CST 2010, time=2010-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605517, encodeId=77bb160551ea9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jan 03 07:33:00 CST 2010, time=2010-01-03, status=1, ipAttribution=)]
    2012-08-21 zhanclean

    好东西~

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=37457, encodeId=72e43e45776, content=Perecft answer! That really gets to the heart of it!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=duygu, createdTime=Sun Sep 27 09:12:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35639, encodeId=01dc3563943, content=如何寻求你们的帮助呢?比如,论文润色,以及发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e16e1638589, createdName=chynmgchy, createdTime=Sat Aug 15 18:17:00 CST 2015, time=2015-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35433, encodeId=053e3543326, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Tue Aug 11 19:11:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7162, encodeId=969fe162ff, content=很有指导意义。好文!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf0a94763, createdName=guhs, createdTime=Tue Jan 28 22:14:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4631, encodeId=182c46318b, content=好东西~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973966269, createdName=zhanclean, createdTime=Tue Aug 21 15:47:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240, encodeId=b77c1240a5, content=Please add line numbering to your text file. <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gwl333333, createdTime=Tue May 11 16:19:00 CST 2010, time=2010-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195, encodeId=16a91195f1, content=请问这个Journal of Pharmaceutical and Biomedical Analysis需要版面费和审稿费吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c116797, createdName=niuniuyun, createdTime=Wed Apr 14 17:32:00 CST 2010, time=2010-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605517, encodeId=77bb160551ea9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jan 03 07:33:00 CST 2010, time=2010-01-03, status=1, ipAttribution=)]
    2010-05-11 gwl333333

    Please add line numbering to your text file.

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=37457, encodeId=72e43e45776, content=Perecft answer! That really gets to the heart of it!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=duygu, createdTime=Sun Sep 27 09:12:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35639, encodeId=01dc3563943, content=如何寻求你们的帮助呢?比如,论文润色,以及发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e16e1638589, createdName=chynmgchy, createdTime=Sat Aug 15 18:17:00 CST 2015, time=2015-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35433, encodeId=053e3543326, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Tue Aug 11 19:11:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7162, encodeId=969fe162ff, content=很有指导意义。好文!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf0a94763, createdName=guhs, createdTime=Tue Jan 28 22:14:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4631, encodeId=182c46318b, content=好东西~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973966269, createdName=zhanclean, createdTime=Tue Aug 21 15:47:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240, encodeId=b77c1240a5, content=Please add line numbering to your text file. <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gwl333333, createdTime=Tue May 11 16:19:00 CST 2010, time=2010-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195, encodeId=16a91195f1, content=请问这个Journal of Pharmaceutical and Biomedical Analysis需要版面费和审稿费吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c116797, createdName=niuniuyun, createdTime=Wed Apr 14 17:32:00 CST 2010, time=2010-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605517, encodeId=77bb160551ea9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jan 03 07:33:00 CST 2010, time=2010-01-03, status=1, ipAttribution=)]
    2010-04-14 niuniuyun

    请问这个Journal of Pharmaceutical and Biomedical Analysis需要版面费和审稿费吗

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=37457, encodeId=72e43e45776, content=Perecft answer! That really gets to the heart of it!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=duygu, createdTime=Sun Sep 27 09:12:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35639, encodeId=01dc3563943, content=如何寻求你们的帮助呢?比如,论文润色,以及发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e16e1638589, createdName=chynmgchy, createdTime=Sat Aug 15 18:17:00 CST 2015, time=2015-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35433, encodeId=053e3543326, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Tue Aug 11 19:11:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7162, encodeId=969fe162ff, content=很有指导意义。好文!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf0a94763, createdName=guhs, createdTime=Tue Jan 28 22:14:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4631, encodeId=182c46318b, content=好东西~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=973966269, createdName=zhanclean, createdTime=Tue Aug 21 15:47:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240, encodeId=b77c1240a5, content=Please add line numbering to your text file. <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gwl333333, createdTime=Tue May 11 16:19:00 CST 2010, time=2010-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195, encodeId=16a91195f1, content=请问这个Journal of Pharmaceutical and Biomedical Analysis需要版面费和审稿费吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c116797, createdName=niuniuyun, createdTime=Wed Apr 14 17:32:00 CST 2010, time=2010-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605517, encodeId=77bb160551ea9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jan 03 07:33:00 CST 2010, time=2010-01-03, status=1, ipAttribution=)]

相关资讯

智能投稿建议系统正式开放

在SCI文章投稿过程中,有许多问题困扰我们的广大临床和科研工作者。到底什么杂志比较好,总没有一个客观标准,尤其是选择投稿杂志时,让人无所适从。 为了普及SCI知识,分享SCI文章发表的经验,MedSci特开设智能投稿建议系统,实现互动,分享SCI文章投稿建议。 具体位置 http://www.medsci.cn/sci/ 本系统与原有的SCI影响因子查询系统无缝集成,您可以搜索任一杂志,然后

SSCI是什么?它的期刊目录有哪些?

注意:SSCI不是SCI,它是社会科学的SCI。 SSCI影响因子查询,可以参考 http://www.medsci.cn/sci/ssci.asp 当然,如果您在知名的大学的话,可以到ISI上直接查询:http://www.thomsonreuters.com/ 以下内容由万跃华教授整理: 社会科学引文索引(Social Sciences Citation Index,简称SS

MedSci 2010年元旦放假通知

   按照国家法定假日规定,2010年元旦放假,从2010年1月1日至3日,合计3天(其中2,3日为周六周日公休)。  假日期间,公司仍然正常接收稿件,但是元月4号以后才会进行处理,祝大家度过一个愉快祥和的元旦。    特别祝福我们广大的客户和网站用户在2010年更进一步,临床和科研更出色,更获丰收!MedSci将一如既往以高品质的服务,回报社会,提升中国临

SCI/EI/SSCI/CSSCI/A&HCI/ISTP详解

什么是SCI? SCI是美国《科学引文索引》的英文简称,其全称为:Science Citation Index,,创刊于1961年,它是根据现代情报学家加菲尔德(Engene Garfield) 1953年提出的引文思想而创立的。时至今日加菲尔德仍是SCI主编之一。SCI是由 ISI( Institute for Scientifi

美国科学引文索引(核心库)(SCI)2009年收录中国期刊名单

MedSci注:以下期刊全是SCI,不包括SCI-E部分,如果包括SCI-E部分,目前收录中国的杂志已超过147种。 美国《科学引文索引(核心库)》(SCI)2009年收录中国期刊名单 Science Citation Index JOURNAL LIST Total journals: 3769 (截止到2009年6月9日) 中国高等学校自然科学学报研究会 对外联络委员

MedSci面向大中华区用户首推MedSci指数

MedSci一直致力于推广科研教育和培训活动。除了向您免费提供大量关于sci写作的资源外,我们还通过会议报告、专业培训班、邮件及网站宣传等诸多形式丰富您对sci论文写作的认识。MedSci发展的理念是改善并提高母语非英语人士,尤其是中国临床和科研工作者的科研论文语言表达质量,节约他们宝贵的科研时间。 但是我们知道,大量的科研人员在选择合适的投稿杂志时,会遇到重重困难。往往只能凭借一知半点的经验